Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist

Gastrin releasing-peptide (GRP) is a potent growth factor in many malignancies. Benign prostatic hyperplasia (BPH) is a progressive age-related proliferation of glandular and stromal tissues; various growth factors and inflammatory processes are involved in its pathogenesis. We have demonstrated tha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rick, Ferenc G., Abi-Chaker, Andrew, Szalontay, Luca, Perez, Roberto, Jaszberenyi, Miklos, Jayakumar, Arumugam R., Shamaladevi, Nagarajarao, Szepeshazi, Karoly, Vidaurre, Irving, Halmos, Gabor, Krishan, Awtar, Block, Norman L., Schally, Andrew V.
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2013
Matèries:
Biological Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574942/
https://ncbi.nlm.nih.gov/pubmed/23359692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1222355110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars